Cerevel Therapeutics gains on report Tempur Sealy will be the subject of FTC meeting
sergeyryzhov/iStock via Getty Images Cerevel Therapeutics (NASDAQ:CERE) rose 2.2% amid a report that the Federal Trade Commission’s closed door meeting on Monday is about Tempur Sealy’s (NYSE:TPX) proposed acquisition of Mattress Firm. Tempur Sealy ticked down 0.5%. The FTC closed-door meeting is expected to decide the fate of the MattressContinue Reading